Pre-clinical evaluation of a divalent liposomal vaccine to control invasive candidiasis
Abstract Candida albicans causes systemic infections with 20–50% mortality in critically ill and immunocompromised patients, despite antifungal treatment. Current therapies face limitations, including toxicity and resistance, underscoring the need for prophylactic vaccines. This study presents a nov...
Saved in:
| Main Authors: | Augusto Costa-Barbosa, Maria Inês Pacheco, Andreia C. Gomes, Tony Collins, Manuel Vilanova, Célia Pais, Alexandra Correia, Paula Sampaio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | npj Vaccines |
| Online Access: | https://doi.org/10.1038/s41541-025-01183-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Invasive candidiasis in children
by: N. N. Klimko, et al.
Published: (2021-07-01) -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
by: Malgorzata Mikulska, et al.
Published: (2011-01-01) -
Technologies of medical diagnosis and treatment of invasive candidiasis in children
by: S.O. Mokia-Serbina, et al.
Published: (2025-03-01) -
Invasive candidiasis among high prevalence neurological patients
by: Weny Rinawati, et al.
Published: (2022-05-01) -
Theoretical Prediction of Divalent Actinide Borozene Complexes
by: Naixin Zhang, et al.
Published: (2024-12-01)